EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Fluoxetine, Fluvoxamine, and Sertraline in Treating Anxiety, Depression, and Obsessive-compulsive Disorder

Mohammad Saeed Maniati, Reza Khosrowabadi, Jamal Shams

Basic and Clinical Neuroscience Journal · 01.03.2026 · 17 (2) · 337-344

DOI: 10.32598/bcn.2026.8104.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic and Clinical Neuroscience Journal, erschienen am 01.03.2026. Verfasst von Mohammad Saeed Maniati und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study aimed to compare the efficacy of three common selective serotonin reuptake inhibitors (SSRIs)—fluoxetine, fluvoxamine, and sertraline—in treating anxiety disorders, major depressive disorder (MDD), and obsessive-compulsive disorder (OCD).

Methods

This eight-week randomized controlled clinical trial included 90 participants who were randomly assigned to receive either fluoxetine (20 mg), ...

Zitieren

APA

Maniati, M. S., Khosrowabadi, R., & Shams, J. (2026). Efficacy of Fluoxetine, Fluvoxamine, and Sertraline in Treating Anxiety, Depression, and Obsessive-compulsive Disorder. Basic and Clinical Neuroscience Journal, 17(2), 337-344. https://doi.org/10.32598/bcn.2026.8104.1

Vancouver

Maniati MS, Khosrowabadi R, Shams J. Efficacy of Fluoxetine, Fluvoxamine, and Sertraline in Treating Anxiety, Depression, and Obsessive-compulsive Disorder. Basic and Clinical Neuroscience Journal. 2026;17(2):337-344. doi:10.32598/bcn.2026.8104.1

BibTeX
@article{Maniati2026,
  author = {Maniati, Mohammad Saeed and Khosrowabadi, Reza and Shams, Jamal},
  title = {Efficacy of Fluoxetine, Fluvoxamine, and Sertraline in Treating Anxiety, Depression, and Obsessive-compulsive Disorder},
  journal = {Basic and Clinical Neuroscience Journal},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {337--344},
  doi = {10.32598/bcn.2026.8104.1}
}
Kostenlos starten →